Health Catalyst announced that it has closed $41 million in funding from existing investors Sequoia Capital, Norwest Venture Partners, Kaiser Permanente Ventures, Sorenson Capital, CHV Capital and Partners HealthCare. The investment enables Health Catalyst to further build out its healthcare analytics platform and assist its clients in systematically and permanently improving efficiency and effectiveness in care delivery. The company plans to invest $50 million in product development over the next 24 months, including production of the next 200 advanced content-driven clinical applications on its roadmap.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.32 USD | -0.41% | +24.91% | -20.95% |
Jul. 09 | Evercore ISI Trims Price Target on Health Catalyst to $8 From $9, Maintains Outperform Rating | MT |
Jul. 01 | Health Catalyst, Inc.(NasdaqGS:HCAT) added to Russell 3000E Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.95% | 432M | |
-5.62% | 250B | |
-16.09% | 61.45B | |
+4.79% | 61.15B | |
+2.75% | 53.92B | |
-0.18% | 40.53B | |
+7.45% | 39.06B | |
+101.23% | 26.38B | |
+2.75% | 21.53B | |
+22.02% | 14.42B |
- Stock Market
- Equities
- HCAT Stock
- News Health Catalyst, Inc.
- Health Catalyst Raises $41 Million to Enable $50 Million Product Development Investment